Article ID Journal Published Year Pages File Type
8647673 Multiple Sclerosis and Related Disorders 2016 7 Pages PDF
Abstract
Practice effect significantly contributes to continuous improvement in SDMT performance during natalizumab treatment: to test cognition, a change in key is required. Practice effect is less pronounced in patients with advanced disease. Cognition remains stable even in patients with progressive disease during more than 2 years of natalizumab treatment indicated by scores corresponding to baseline after changing the key.
Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Genetics
Authors
, , ,